Legionella pneumophila, a Gram-negative bacillus, is the causative agent of Legionnaire’s
disease, a form of severe community-acquired pneumonia. Infection can have high morbidity, …

The aim of this review was to describe the current knowledge of Legionnaires’ disease (LD)
illustrated by the epidemiological situation in France in 2013. LD is a severe pneumonia …

… DNA sequencing and PCR–restriction fragment length polymorphism showed a 2047 A-to-G
mutation in the 3 copies of the 23S rRNA gene. Monitoring for macrolide resistance is …

… G less than 5 g/L, human immunodeficiency virus infection, or immunosuppressive (IS)
drugs. The following clinical data were recorded for primary and ulterior LD episodes: fever, …

… : Weigh 1.20 g NaCl, 0.04 g of MgSO 4 ⋅7H 2 O, 1.42 g of Na 2 HPO 4 and 1.36 g of KH 2
PO 4 , and bring the volume up to 100 mL with distilled water. Solution B: weigh 0.04 g of CaCl …

Endemic strains of Legionella pneumophila sequence type 1 (ST1), in particular the ST1/Paris
pulsotype, are dispersed worldwide and represent about 10% of culture-proven clinical …

Identification and antimicrobial susceptibility testing (AST) are critical steps in the
management of bloodstream infections. Our objective was to evaluate the performance of the …

Legionnaires' disease is a severe pneumonia mainly caused by Legionella pneumophila
that is treated by antibiotics. The purpose of this study was to describe the susceptibility of …

Objectives: A previous study on 12 in vitro-selected azithromycin-resistant Legionella
pneumophila lineages showed that ribosomal mutations were major macrolide resistance …

… C-to-T and -G transitions were responsible for higher MICs than the C-to-A transition, as …
, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, and Verheij TJ. 2011. …